Vesicle Therapeutics Inc. — Department of Health and Human Services SBIR Phase I: 4

Vesicle Therapeutics Inc. — SBIR Phase I award from Department of Health and Human Services.

Amount
$475,152
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase I
Topic
4
Solicitation
PHS-2022-1
NAICS
Place of performance
CO
Period

Description

To develop a safe and effective platform technology for delivering gene therapy solutions to the central nervous system.